Taiwan Bio Therapeutics Co., Ltd (6892.TWO)
TWD 31.1
(-3.12%)
TWD 31.1
(-3.12%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 20.48 Million TWD | -49.63% |
| 2022 | 40.66 Million TWD | -82.44% |
| 2021 | 231.56 Million TWD | 806.14% |
| 2020 | -32.79 Million TWD | 0.0% |
| 2019 | - TWD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 Q2 | -146.99 Million TWD | -461.48% |
| 2023 FY | 20.48 Million TWD | -49.63% |
| 2023 Q4 | 20.48 Million TWD | 113.93% |
| 2022 FY | 40.66 Million TWD | -82.44% |
| 2022 Q4 | 40.66 Million TWD | 0.0% |
| 2021 FY | 231.56 Million TWD | 806.14% |
| 2020 FY | -32.79 Million TWD | 0.0% |
| 2019 FY | - TWD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| SYN-TECH Chem. & Pharm. Co., Ltd. | -264.16 Million TWD | 107.754% |
| Level Biotechnology Inc. | -453.9 Million TWD | 104.513% |
| TaiMed Biologics Inc. | 499.84 Million TWD | 95.902% |
| GlycoNex Incorporation | -148.56 Million TWD | 113.787% |
| GeneReach Biotechnology Corp. | 40.26 Million TWD | 49.131% |
| OBI Pharma, Inc. | -398.22 Million TWD | 105.144% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 137.99 Million TWD | 85.157% |
| Genomics BioSci & Tech. Co.,Ltd. | 30.57 Million TWD | 33.014% |
| Visgeneer Inc. | 31.28 Million TWD | 34.526% |
| Neith Corporation | -150.31 Million TWD | 113.627% |
| Lumosa Therapeutics Co., Ltd. | -412.63 Million TWD | 104.964% |
| Medigen Vaccine Biologics Corporation | 621.53 Million TWD | 96.704% |
| TaiwanJ Pharmaceuticals Co., Ltd. | -57.65 Million TWD | 135.525% |
| Enimmune corporation | -314.15 Million TWD | 106.52% |
| TaiRx, Inc. | -147.86 Million TWD | 113.852% |
| CHO Pharma, Inc. | -203.79 Million TWD | 110.051% |
| BioLASCO Taiwan Co., Ltd. | -84.76 Million TWD | 124.165% |
| Sunny Pharmtech Inc. | 120.87 Million TWD | 83.054% |
| Ever Supreme Bio Technology Co., Ltd | -330.54 Million TWD | 106.197% |
| Feng Chi Biotech Corp. | -19.81 Million TWD | 203.382% |
| Lukas Biomedical Inc. | 50.75 Million TWD | 59.643% |
| RBC Bioscience Corporation | 422.18 Million TWD | 95.148% |
| NaviFUS Corp. | -123.12 Million TWD | 116.635% |
| BRIM Biotechnology, Inc. | -944.4 Million TWD | 102.169% |
| Shine-On BioMedical Co.,Ltd. | -101.48 Million TWD | 120.183% |
| Great Novel Therapeutics Biotech & Medicals | -165.17 Million TWD | 112.401% |
| Sagittarius Life Science Corp | -120.57 Million TWD | 116.988% |
| Bio Preventive Medicine Corp. | 31.8 Million TWD | 35.606% |
| Advagene Biopharma Co., Ltd. | -64.32 Million TWD | 131.845% |
| BioGend Therapeutics Co., Ltd. | -317.41 Million TWD | 106.453% |
| G&E Herbal Biotechnology Co., Ltd. | -134.25 Million TWD | 115.257% |
| Andros Pharmaceuticals Co.,Ltd | -241.89 Million TWD | 108.468% |
| Lin BioScience, Inc. | -3.21 Billion TWD | 100.636% |
| Anti-Microbial Savior BioteQ Co., Ltd | -77.04 Million TWD | 126.586% |
| AP Biosciences Inc | -196.52 Million TWD | 110.422% |
| Sunmax Biotechnology Co., Ltd. | -680.6 Million TWD | 103.01% |
| Syngen Biotech Co.,Ltd. | 314.87 Million TWD | 93.495% |
| EirGenix Inc. | -4.58 Billion TWD | 100.446% |
| Pharmosa Biopharm Inc. | -829.69 Million TWD | 102.469% |
| Mycenax Biotech Inc. | 207 Million TWD | 90.105% |
| SynCore Biotechnology Co.,Ltd | -262.58 Million TWD | 107.801% |
| Eusol Biotech Co.,Ltd. | -209.33 Million TWD | 109.785% |
| NeoCore Technology Co., Ltd. | -196.39 Million TWD | 110.429% |
| VBI | -25.31 Million TWD | 180.909% |
| BiOptic Inc. | 12.59 Million TWD | -62.667% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 74.05 Million TWD | 72.339% |
| Sinew Pharma Inc. | -160.34 Million TWD | 112.774% |
| Greenyn Biotechnology Co., Ltd | -337.37 Million TWD | 106.071% |
| Medigen Biotechnology Corp. | 688.73 Million TWD | 97.026% |
| 3D Global Biotech Inc. | -11.43 Million TWD | 279.094% |
| Intech Biopharm Corporation | 1.35 Billion TWD | 98.491% |
| Oneness Biotech Co., Ltd. | -414.87 Million TWD | 104.937% |
| TWi Biotechnology, Inc. | -143.86 Million TWD | 114.238% |
| TCI GENE Inc. | -689.25 Million TWD | 102.972% |
| MegaPro Biomedical Co., Ltd | -118.93 Million TWD | 117.222% |
| Senhwa Biosciences, Inc. | -1.3 Billion TWD | 101.565% |
| NatureWise Biotech & Medicals Corporation | -101.87 Million TWD | 120.107% |
| PharmaEngine, Inc. | -860.8 Million TWD | 102.38% |
| Savior Lifetec Corporation | -812.54 Million TWD | 102.521% |
| TaiGen Biopharmaceuticals Holdings Limited | -299.96 Million TWD | 106.828% |
| Meribank Biotech Co., Ltd | -365.41 Million TWD | 105.605% |
| Acepodia, Inc. | -6.02 Billion TWD | 100.34% |
| Caliway Biopharmaceuticals Co., Ltd. | -3.4 Billion TWD | 100.602% |